Evaluation and management of insomnia, muscle cramps, fatigue, and itching in cirrhotic patients
Christopher Moore – 29 January 2016
Bundled strategies against infection after liver transplantation: Lessons from multidrug‐resistant Pseudomonas aeruginosa
Asahi Sato, Toshimi Kaido, Taku Iida, Shintaro Yagi, Koichiro Hata, Hideaki Okajima, Shunji Takakura, Satoshi Ichiyama, Shinji Uemoto – 29 January 2016 – Infection is a life‐threatening complication after liver transplantation (LT). A recent outbreak of multidrug‐resistant Pseudomonas aeruginosa triggered changes in our infection control measures. This study investigated the usefulness of our bundled interventions against postoperative infection after LT.
Integrating daclatasvir into hepatitis c therapy
Omobonike Oloruntoba, Andrew J. Muir – 29 January 2016
Silymarin in the treatment of liver diseases: What is the clinical evidence?
Peter Ferenci – 29 January 2016
Nutrition, fluid, and electrolytes in chronic liver disease
Miguel A. Lalama, Yasser Saloum – 29 January 2016
Evaluation and management of insomnia, muscle cramps, fatigue, and itching in cirrhotic patients
Christopher Moore – 29 January 2016
Reply
David Hervás, Agustín Lahoz – 29 January 2016
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
Mohammed Eslam, Alessandra Mangia, Thomas Berg, Henry Lik Yuen Chan, William L. Irving, Gregory J. Dore, Maria Lorena Abate, Elisabetta Bugianesi, Leon A. Adams, Mustafa A.M. Najim, Luca Miele, Martin Weltman, Lindsay Mollison, Wendy Cheng, Stephen Riordan, Janett Fischer, Manuel Romero‐Gomez, Ulrich Spengler, Jacob Nattermann, Antony Rahme, David Sheridan, David R. Booth, Duncan McLeod, Elizabeth Powell, Christopher Liddle, Mark W.
The changing face of liver transplantation for acute liver failure: Assessment of current status and implications for future practice
Mhairi C. Donnelly, Peter C. Hayes, Kenneth J. Simpson – 28 January 2016 – The etiology and outcomes of acute liver failure (ALF) have changed since the definition of this disease entity in the 1970s. In particular, the role of emergency liver transplantation has evolved over time, with the development of prognostic scoring systems to facilitate listing of appropriate patients, and a better understanding of transplant benefit in patients with ALF.
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+)
Vincent Leroy, Peter Angus, Jean‐Pierre Bronowicki, Gregory J. Dore, Christophe Hezode, Stephen Pianko, Stanislas Pol, Katherine Stuart, Edmund Tse, Fiona McPhee, Rafia Bhore, Maria Jesus Jimenez‐Exposito, Alexander J. Thompson – 28 January 2016 – Patients with hepatitis C virus (HCV) genotype 3 infection, especially those with advanced liver disease, are a challenging population in urgent need of optimally effective therapies.